Conveniently located in Silicon Valley, California, we focus on creating innovative materials that enhance existing technologies and create new opportunities for a sustainable future.
Particle synthesis, surface derivatization, passivation, bioconjugation, biocompatibility, characterization
Nanoparticle, nanowire, and nanotube infused polymers with enhanced electrical, thermal, and structural properties.
From conductive and dielectric inks to exotic electro-responsive emulsions
Functional ink formulations for diverse applications
Nanoparticles (NP) for Biosensor Applications
Gold and Silver nanoparticles
Polymeric luminescent particles (Fluorophores and Lanthanide chelates)
Reverse emulsions, micro-emulsion, Liposomes, lipid NPs
Bioconjugation and biocompatible coatings
Lateral flow assays
Electrodes and membranes
Self-Assembled nano and micro-structured materials
Thermodynamically stable microemulsions
For application that range from nanodevices to medtech to sustainable environmental remediation materials, we formulate custom solutions to fit every need.
Tailored to your individual needs
SmallTech is an interdisciplinary technology consulting company focused on sustainability. Specializes in sensing and environmental impact mitigation technologies. SmallTech has a core team of 6 PhDs (2 EE, 1ME, 2 Physics, 1 Chemistry) that cumulatively hold
143 issued patents ($Billions in profits for assignees) and more than 5,000 citations from research papers in nanotechnology, MEMS, and optics.
Extensive industry experience at top research labs.
Panamint is a team of scientists, nanotechnologists designers, and industry veterans, who have come together with a vision of taking printed electronics to the next level. We are building a portfolio of innovative printed components that include proprietary printed displays, batteries/energy storage solutions, sensors, and functional inks, all as part of a larger goal of integration into systems and devices with a focus on sustainability and novel functionality.
PRI has discovered and served as an incubator for a number of technologies and pharmaceutical projects that subsequently were licensed to development partners or incorporated into PRI portfolio companies. The Institute has a staff of 15 medical scientists (10 with MD and/or PhD degrees) with expertise in medicinal and organic chemistry, pharmacology, molecular and cell biology, plant molecular biology, oncology, immunology, infectious diseases and medicine.